Effects, when they occur, are usually temporary and require maintenance
But the financial burden is just one piece of it
Needle size matters because it decides which layer of tissue the B12 reaches, how comfortable the injection is, and how cleanly it goes in
Other integrated safety analyses have reported similar IRs of VTE in AA and AD, including baricitinib in AD (IR, 0.09/100 PY)32 and AA (IR, 0.1/100 PY),24 abrocitinib in AD (IR, 0.3/100 PY),33 and upadacitinib in AD (IRs, 0.3/100 PY [15mg], 0.2/100 PY [30mg]).25 EMA safety recommendations for JAK inhibitors (tofacitinib, baricitinib, upadacitinib, abrocitinib, filgotinib) do not include ritlecitinib.33 Additional long-term data are needed to assess VTE risk with selective JAK3/TEC inhibition in AA.25 Neuroaudiological events In chronic preclinical toxicology studies in dogs, reversible axonal dystrophy in the cerebellum was observed with ritlecitinib at exposures 7.4 times the approved human dose (50mg).25 At 33 times this dose, axonal dystrophy caused reversible hearing loss and alterations in brainstem auditory evoked potential (BAEP) waveforms

By integrating metabolic biomarkers with genomic and metabolomic data, personalized intervention strategies can be developed, particularly for patients with metabolic disorders
10.1534/genetics.115.185678 9 ChenJ.MohammadA.PazdernikN.HuangH.BowmanB.TycksenE.et al (2020)